Provided by Tiger Trade Technology Pte. Ltd.

Prestige

52.64
+0.86001.66%
Post-market: 52.640.00000.00%16:15 EDT
Volume:592.57K
Turnover:31.27M
Market Cap:2.49B
PE:14.72
High:53.57
Open:52.50
Low:52.28
Close:51.78
52wk High:71.07
52wk Low:42.62
Shares:47.32M
Float Shares:46.69M
Volume Ratio:1.64
T/O Rate:1.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.58
EPS(LYR):3.91
ROE:9.12%
ROA:4.58%
PB:1.30
PE(LYR):13.46

Loading ...

Prestige Consumer Healthcare SVP Operations Jeffrey Zerillo disposes 656 shares worth $35,683.61

Reuters
·
May 12

Buy Rating Reaffirmed on PBH with Earnings Growth Drivers, Balance Sheet Improvement and Unchanged $140 Price Target

TIPRANKS
·
May 12

MBX Biosciences Provides Obesity Portfolio Update Including Initial Phase 1 Data for MBX 4291 Supporting Potential for Once-Monthly Dosing

GlobeNewswire
·
May 11

Has Prestige Consumer Healthcare (PBH) Fallen Too Far After Its 37% One-Year Share Price Drop?

Simply Wall St.
·
May 10

Stifel Nicolaus Keeps Their Buy Rating on Premium Brands (PBH)

TIPRANKS
·
May 08

Top Prestige Consumer Executive Makes Notable Stock Move

TIPRANKS
·
May 08

Prestige Consumer price target lowered to $65 from $77 at Oppenheimer

TIPRANKS
·
May 07

Prestige Consumer Healthcare : Oppenheimer Cuts Target Price to $65 From $77

THOMSON REUTERS
·
May 07

Press Release: MBX Biosciences Reports First Quarter 2026 Financial Results and Corporate Highlights

Dow Jones
·
May 07

MBX Biosciences Announces Appointment of Mark Soued as Chief Commercial Officer and Inducement Grant Award

GlobeNewswire
·
May 07

Press Release: Amylyx Pharmaceuticals Reports First Quarter 2026 Financial Results

Dow Jones
·
May 07

Prestige Consumer Healthcare Senior VP Operations Jeffrey Zerillo disposes 1,589 shares for $86,993.76

Reuters
·
May 07

RBC Capital Reaffirms Their Buy Rating on Premium Brands (PBH)

TIPRANKS
·
May 06

Earning Preview: Prestige this quarter’s revenue is expected to increase by 1.86%, and institutional views are bullish

Earnings Agent
·
May 06

Premium Brands (PBH) Receives a Buy from CIBC

TIPRANKS
·
Apr 30

Prestige Consumer Healthcare to Release Fiscal 2026 Fourth Quarter and Year-End Earnings Results

GlobeNewswire
·
Apr 30

MBX Biosciences to Host In-Person and Virtual Obesity Day on May 11, 2026 to Discuss Expanding Obesity Portfolio

GlobeNewswire
·
Apr 23

Prestige Biopharma IDC Files Patent for Next-Generation Antibody Delivery Platform 'IDC224'… Driving Innovation in Subcutaneous (SC) Formulations

prnewswire
·
Apr 23

Prestige Estates Projects Hits Early Sales of INR25 Billion for New Project in Hyderabad, India

MT Newswires Live
·
Apr 21

Prestige Estates Posts Record FY26 Sales and Collections on Broad-Based Real Estate Momentum

TIPRANKS
·
Apr 15